This is a standard proxy filing for an annual shareholder meeting. No immediate trading action is required. Monitor the voting results for the shareholder proposal on an independent chair, as a significant vote could signal governance concerns.
Price Chart
Executive Summary
AbbVie Inc. is holding its 2026 Annual Meeting for shareholders. The proxy statement includes proposals to elect four Class II directors, ratify the independent auditor, approve executive compensation (Say on Pay), amend the certificate of incorporation to eliminate supermajority voting, and vote on a shareholder proposal to adopt an independent chair. This is routine corporate governance material.
Key Facts
- Annual meeting scheduled for May 8, 2026.
- Four Class II directors are up for election: Jennifer L. Davis, Melody B. Meyer, Robert A. Michael, and Frederick H. Waddell.
- Proposal to ratify Ernst & Young LLP as the independent auditor for 2026.
- Say on Pay advisory vote on executive compensation.
- Management proposal to amend the certificate of incorporation to eliminate supermajority voting.
- Shareholder proposal to adopt a policy requiring an independent chair.
Financial Impact
No direct financial impact from this filing.
Risk Factors
- A significant vote against management on the independent chair proposal could indicate shareholder dissatisfaction with current governance, potentially leading to future governance changes or activist pressure.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001104659-26-033391 |
| Document: 0001104659-26-033391-index-headers.html | 0001104659-26-033391 |
| Document: 0001104659-26-033391-index.html | 0001104659-26-033391 |
| Document: 0001104659-26-033391.txt | 0001104659-26-033391 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | Court Ruling | $261.77 $264.48 | ▲ +1.04% | ▼ −0.62% | $259.94 (−0.70%) |
Sep 3, 2026 29d ago | 8-K | $260.21 $257.12 | ▼ −1.19% | ▼ −0.04% | $259.94 (−0.10%) |
Aug 5, 2026 8w ago | 8-K | $243.87 $250.82 | ▲ +2.85% | ▲ +1.64% | $259.94 (+6.59%) |
Aug 3, 2026 8w ago | Institutional Cluster | $245.10 $247.97 | ▲ +1.17% | ▼ −0.86% | $259.94 (+6.05%) |
Aug 3, 2026 8w ago | Court Ruling | $245.10 $247.97 | ▲ +1.17% | ▼ −0.86% | $259.94 (+6.05%) |
Jul 31, 2026 9w ago | 8-K | $250.94 $246.04 | ▼ −1.95% | ▼ −5.46% | $259.94 (+3.59%) |
Jul 27, 2026 9w ago | Court Ruling | $256.91 $250.94 | ▼ −2.32% | ▼ −3.40% | $259.94 (+1.18%) |
Jun 22, 2026 14w ago | 8-K | $230.01 $254.31 | ▲ +10.56% | ▲ +11.02% | $259.94 (+13.01%) |
May 18, 2026 19w ago | Court Ruling | $209.41 $213.12 | ▲ +1.77% | ▲ +0.15% | $259.94 (+24.13%) |
Apr 29, 2026 22w ago | 8-K | $203.89 $206.11 | ▲ +1.09% | ▼ −2.02% | $259.94 (+27.49%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access